Company Filing History:
Years Active: 2012-2019
Title: David A. Saperstein: Innovator in Retinoids and Opsin Agonists
Introduction
David A. Saperstein is a prominent inventor based in Seattle, Washington, recognized for his significant contributions to the field of synthetic retinoids and their applications. With a total of seven patents, Saperstein's work has advanced medical research, particularly in the realms of vision and therapeutic applications.
Latest Patents
Saperstein's latest patents include innovative compositions and methods concerning retinoid replacements and opsin agonists. His research provides compositions of synthetic retinoids that serve as replacements for natural retinoids and act as opsin agonists. These advancements are pivotal in developing new treatment methodologies in vision science and related fields.
Career Highlights
David A. Saperstein has established a robust career at the University of Washington, where he engages in groundbreaking research. His dedication and expertise have led to a remarkable series of inventions that enhance understanding and treatment of visual disorders.
Collaborations
Throughout his career, Saperstein has collaborated with esteemed colleagues, including Krzysztof Palczewski and Tadao Maeda. These partnerships have fostered a dynamic research environment, contributing to the development of innovative solutions in vision-related technologies.
Conclusion
David A. Saperstein's work in the field of synthetic retinoids exemplifies the critical intersection of innovation and research. His numerous patents not only underscore his inventiveness but also highlight the importance of collaborative efforts in advancing scientific knowledge and medical applications. Saperstein's contributions continue to inspire future innovations in the field.